Your session is about to expire
← Back to Search
Other
Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon (AchillesRCT Trial)
N/A
Waitlist Available
Led By Dr. Mark Glazebrook, MD
Research Sponsored by Mark Glazebrook
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 year
Awards & highlights
No Placebo-Only Group
Summary
The proposed trial is a multi-centre prospective randomized controlled trial comparing outcomes of patients with acute Achilles tendon ruptures treated either non-operatively or with open operative tendon repair. All patients will undergo accelerated functional rehabilitation. The primary outcome measure is Achilles tendon re-rupture rate.
Eligible Conditions
- Ruptured Achilles Tendon
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Operative vs non operative Treatment of acute ruptures of Achilles tendon.
Secondary study objectives
Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: non-operativeExperimental Treatment1 Intervention
cast applied within 48 hours
Group II: operativeActive Control1 Intervention
cast applied within 48 hours and surgery within 14 days
Find a Location
Who is running the clinical trial?
Nova Scotia Health AuthorityOTHER
288 Previous Clinical Trials
94,342 Total Patients Enrolled
Mark GlazebrookLead Sponsor
Dr. Mark Glazebrook, MDPrincipal InvestigatorCapital Health District Authority